VANDA PHARMACEUTICALS INC (VNDA) — insider trading
Health Care · NASDAQ
VANDA PHARMACEUTICALS INC (VNDA) has 9 reported SEC Form 4 insider transactions in our data (latest 2026-06-04).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Mitchell Stephen Ray | Director | Grant / award / vesting | 41,600 | — | $0 | Form 4 |
| 2026-06-04 | Honore Tage | Director | Grant / award / vesting | 41,600 | — | $0 | Form 4 |
| 2026-06-04 | Ward Anne Sempowski | Director | Grant / award / vesting | 41,600 | — | $0 | Form 4 |
| 2026-06-04 | DUGAN RICHARD W | Director | Grant / award / vesting | 41,600 | — | $0 | Form 4 |
| 2026-06-04 | Duncan Charles Cliff | Director | Grant / award / vesting | 41,600 | — | $0 | Form 4 |
| 2026-06-04 | Chrousos Phaedra | Director | Grant / award / vesting | 41,600 | — | $0 | Form 4 |
| 2026-06-04 | McGuire Daniel Patrick | Officer (SVP, GC and Secretary) | Grant / award / vesting | 80,000 | — | $0 | Form 4 |
| 2026-05-18 | Mitchell Stephen Ray | Director | Bona fide gift | 25,836 | — | $0 | Form 4 |
| 2026-04-22 | Duncan Charles Cliff | Director | Grant / award / vesting | 57,101 | — | $0 | Form 4 |
Ask the chat about VNDA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: VANDA PHARMACEUTICALS INC (VNDA).
Last updated 2026-06-04 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.